More articles from COPD

Exploring the potential benefits of digital health technology for the management of COPD: a qualitative study of patient perceptions
Patrick Slevin, Threase Kessie, John Cullen, Marcus W. Butler, Seamas C. Donnelly, Brian Caulfield

ERJ Open Research Apr 2019, 5 (2) 00239-2018; DOI: 10.1183/23120541.00239-2018
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
Alexander G. Mathioudakis, Mia Moberg, Julie Janner, Pablo Alonso-Coello, Jørgen Vestbo

ERJ Open Research Apr 2019, 5 (2) 00072-2019; DOI: 10.1183/23120541.00072-2019
Diagnosis and management of α₁-antitrypsin deficiency in Europe: an expert survey
Ildikó Horváth, Maria Canotilho, Jan Chlumský, Joanna Chorostowska-Wynimko, Luciano Corda, Eric Derom, Joachim H. Ficker, Meinhard Kneussl, Marc Miravitlles, Maria Sucena, Gabriel Thabut, Alice M. Turner, Emily van ’t Wout, N. Gerard McElvaney

ERJ Open Research Feb 2019, 5 (1) 00171-2018; DOI: 10.1183/23120541.00171-2018
Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohort
Tom M.A. Wilkinson, Emmanuel Aris, Simon C. Bourne, Stuart C. Clarke, Mathieu Peeters, Thierry G. Pascal, Laura Taddei, Andrew C. Tuck, Viktoriya L. Kim, Kristoffer K. Ostridge, Karl J. Staples, Nicholas P. Williams, Anthony P. Williams, Stephen A. Wootton, Jeanne-Marie Devaster

ERJ Open Research Feb 2019, 5 (1) 00248-2018; DOI: 10.1183/23120541.00248-2018
Treatment response in COPD: does FEV₁ say it all? A post hoc analysis of the CRYSTAL study
Konstantinos Kostikas, Timm Greulich, Alexander J. Mackay, Nadine S. Lossi, Maryam Aalamian-Mattheis, Xavier Nunez, Veronica A. Pagano, Francesco Patalano, Andreas Clemens, Claus F. Vogelmeier

ERJ Open Research Feb 2019, 5 (1) 00243-2018; DOI: 10.1183/23120541.00243-2018
Impact of pre-enrolment medication use on clinical outcomes in SUMMIT
Jørgen Vestbo, Mark Dransfield, Julie A. Anderson, Robert D. Brook, Peter M.A. Calverley, Bartolome R. Celli, Nicholas J. Cowans, Courtney Crim, Fernando Martinez, David E. Newby, Julie Yates, Peter Lange

ERJ Open Research Feb 2019, 5 (1) 00203-2018; DOI: 10.1183/23120541.00203-2018
Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study
Chenglong Li, Yumin Zhou, Sha Liu, Mengning Zheng, Jinzhen Zheng, Huanhuan Peng, Zhishan Deng, Nanshan Zhong, Pixin Ran

ERJ Open Research Feb 2019, 5 (1) 00175-2018; DOI: 10.1183/23120541.00175-2018
Patients' perspectives on COPD: findings from a social media listening study
Nigel S. Cook, Konstantinos Kostikas, Jean-Bernard Gruenberger, Bhavik Shah, Purnima Pathak, Vinay Preet Kaur, Alaknanda Mudumby, Rajat Sharma, Florian S. Gutzwiller

ERJ Open Research Feb 2019, 5 (1) 00128-2018; DOI: 10.1183/23120541.00128-2018
COPD is associated with an increased risk of peripheral artery disease and mortality
Natalie Terzikhan, Lies Lahousse, Katia M.C. Verhamme, Oscar H. Franco, M. Arfan Ikram, Bruno H. Stricker, Guy G. Brusselle

ERJ Open Research Oct 2018, 4 (4) 00086-2018; DOI: 10.1183/23120541.00086-2018
Randomised controlled trial of cognitive behavioural therapy in COPD
Karen Heslop-Marshall, Christine Baker, Debbie Carrick-Sen, Julia Newton, Carlos Echevarria, Chris Stenton, Michelle Jambon, Joanne Gray, Kim Pearce, Graham Burns, Anthony De Soyza

ERJ Open Research Oct 2018, 4 (4) 00094-2018; DOI: 10.1183/23120541.00094-2018

Main menu

User menu

Search

More articles from COPD

Pages